caribbean travel ltd

Caribbean Travel And Tours

Antigua and barbuda, british virgin islands, st. kitts and nevis, saint lucia, st. vincent and the grenadines, trinidad and tobago, turks & caicos, us virgin islands.

DISCOVER THE CARIBBEAN

Welcome to your one-stop travel portal, popular experiences.

Saint Lucia Jazz and Arts Festival

April 30 - May 12, 2024 - Experience the magic of the Saint Lucia Jazz & Arts Festival, a renowned musical celebration on the lush island for over 30 years.

Grenada Chocolate Festival

May 17th to 21st - Savor the flavors of Grenada at the annual Chocolate Festival.

Barbados Reggae Weekend

April 26 - 29, 2024 - Experience the captivating allure of the Barbados Reggae Weekend, a three-day musical extravaganza.

Aruba Soul Beach Music Festival 2024

May 22nd to May 27th - Prepare to lose yourself in the rhythm of Aruba's Soul Beach Music Festival 2024

CARIBBEAN DESTINATIONS

OUR SERVICES

Creating Memorable Experiences

• Build your own trip
• Holiday match maker- Not just hotel and flight… we create memorable experiences
• Customized services and travel plans tailored for you
• Concierge services

Not sure where to start? Planning, researching, negotiating, and coordinating services tailored for your special event

Discover the value of partnership. Receive hands on support and access the best of the Caribbean Access to resources and training

• Receive special offers
• Exclusive giveaways
• Inspiration for your next memorable trip
• Submit your video, photo or story
• Submit a review

Subscribe to our newsletter to get regular updates and blog posts.

Share your experience

How Our Business Works

Step 01/ contact.

Contact us by completing our trip request form + introduce yourself. We’ll review your details and follow up with more questions and/or schedule a complimentary 15-minute phone consultation to learn more about your travel wants + needs and explain how we put our expertise to work for you.

STEP 02/ Commit

During this initial consultation, we will let you know if we think our company can be of assistance to you. If so, we will send you a link to pay our professional service fee , allowing us to start the research + planning process on your behalf. **Trip minimums do apply.

STEP 03/ Review

Sit back and relax while we take all of the details you shared and build a personalized list of trip ideas for you. Our initial proposal arrives in your inbox in as little as 24-48 hours, depending on the scope of your plans.

STEP 04/ Fine-tune

Next, in a collaborative effort, we will fine-tune your final itinerary by answering any questions you might have and providing resources for you to review, going over the options for activities, dining, and entertainment at your destination so you are able to get the “big picture” of what this trip experience will be like.

STEP 05/ Book the Trip

Once a final itinerary has been decided upon, we will place the trip on a courtesy hold (if possible) and send you an invoice with the full payment schedule, cancellation policy, and travel insurance options.

STEP 06/ Documentation

Once paid, you are sent a receipt followed by a complete set of travel documents. Our clients travel with clear travel instructions, local contacts for support, and emergency numbers that are staffed 24/7. All of this information is relayed to you in real time on our online platform.

STEP 07/ Icing on the Cake

We aren’t done yet. We provide concierge-style travel planning and will happily share with you our personal recommendations based on our most memorable experiences, adventures, restaurants, wellness activities, along with any travel tips that might enhance your trip. We remain at your service before, during, and after you travel.

Sounds simple enough, right? That’s the point! The best vacations are the ones you don’t have to plan for yourself. If you think we’d be a good match, let’s start planning!

Smart travelers know it is more important than ever to have a trusted advocate by your side.

When we plan your travel, we put our 20+ years of experience to work for you.

CARIBBEAN PRIVATE TRAVEL

Bespoke cultural experiences, immersive travel solutions.

for individuals and small groups

We are a local agency specialized in experiential luxury travel. It’s more important than ever before to have at your fingertips a discerning grassroots-savvy operator that can get you into the best villas and restaurants, away from the crowds and off the beaten track. Owner-run Caribbean Private Travel is defined by our deep knowledge and love for the Caribbean. With more than 15 years of travel expertise, our grass-roots connections are second to none (and we make new connections every month). We can craft any type of experience.

Success! Message received.

Already have an account? Login to check loyalty balance or redeem rewards

• Shopping Lists
• Wedding & Gift Registry
• Sign in or Create an account

• Contact Customer Service 1-876-906-3140

Top Sellers

• Destinations
• How to Submit Payment

Caribbean and Latin Travel Consultant Limited

40 A New Kingston Business Centre 30 Dominica Drive. Kingston 5, Jamaica, W.I.

Phone: 876-906-3140 Mobile:  876-472-2127

Email: [email protected] Telegram:   https://t.me/caribbeanlatintravel

Do you have a question about our products and services? Are you looking for an item that’s not listed or available on our site? We will be happy to help with all of your questions. Please complete the form below and someone will contact you as soon as possible. 

• Privacy Policy
• Track Your Order
• My Recent Orders
• My Messages
• Centrally located to serve your party rides rental needs, Wild rides understands that your events should leave lasting memories... more

Customer Service

1-876-906-3140 1-876-472-2127, secure payment powered by ncb gateway.

All prices are in USD . Copyright 2024 Caribbean and Latin Travel Consultant Limited. Sitemap | Powered by HB-Commerce

Dreaming of a Caribbean getaway?

Caribbean destinations.

The Caribbean is known for its favourable weather and sandy beaches, but each Island is unique with differing culture, food and geography. From the more popular Caribbean destinations to the lesser-known gems, we cover them all. Let us help you discover the Caribbean.

Book now, Pay later

Up to 9 months 0% credit.

To make booking easier Caribbee can offer you a flexible interest-free payment plan. Learn more

Exceptional

Value guaranteed.

Exceptional value guaranteed Our team works tirelessly to deliver exceptional value - always.

As one of the UK’s longest running Caribbean travel specialists we are experts in our field.

By ATOL & ABTA

All our flight and holiday packages are ATOL* protected, as are our flight only bookings where tickets are not issued within 24 hours of receiving a payment.

Caribbean Specialists

We are trusted by thousands and our customers come back to us time after time.

Welcome to Caribbean Travel

Caribbean Travel Ltd

• Last Updated: {page_last_updated}
• {company_category}
• Company No. 12012958

Comprehensive Business Report

• What's included in this report?
• Credit Scores & Limits
• CCJ's, Gazette Notices & Charges
• All Director and Secretaries Information
• 5 Year Financial Accounts
• Shareholders & Group Structure
• Contact Data & Trading Addresses
• 7 Day Money Back Guarantee
• Includes Downloadable Report [ View Sample ]

Stay updated with Caribbean Travel Ltd

Upgrade to view Credit Score and Limit

Upgrade to view Shareholders

Upgrade to view Group Structure

Businesses in Jamaica » Business » Travel Agencies and Bureaus in Jamaica contact number and location » Caribbean and Latin Travel Consultants Ltd

Caribbean and Latin Travel Consultants Ltd

Address: Suite 40A New Kingston Business Cen Kingston 5 Jamaica

Email: [email protected]

Website: www.caribbeanlatintravel.com

Travel Agencies and Bureaus in Jamaica contact number and location

876-906-3140

Description:

The Caribbean and Latin Travel Consultant Limited, the official Sales Agent in Jamaica for Aerogaviota Airlines, which is the only airline that has direct flights between Jamaica and Cuba. In addition to being the Agent of the airline, we are also the tour operator that connects Cuba and Jamaica with customised milti-destination packages to make one Caribbean vacation package between the countries forging a multi-cultural / multi-language, never forgetting experience. Whether it is for vacation, work, study, health improvement, wedding, events, visiting friends and family, we have the best and most affordable multicultural encounter in the Caribbean.

Related Business

Travisio travel – best travel agency in kingston jamaica, unique tours jamaica – travel agencies in montego bay, expressionz travels, kml enterprise – we offer the very best rates for jamaica’s top hotels, dream destinations limited – travel agencies & bureaus kingston, inip aplus consulting limited, travel together tours jamaica, lins travel fusion, island bwoy travel, chadwah p print and travel services, jamaica terrific travel tours, playa caribbean vacations, travoline travel services pvt ltd, travel solutions ltd, travel partners ltd, trafalgar travel ltd, steep international limited, praise travel ltd, national travel serv, leisure for pleasure holidays & tours, compact vacations, budget vacations, bj’s travel ltd, jetaway travel service ltd, total travel servs ltd, global travel serv ltd, unique travel serv ltd, atlas travel ltd, travel incorporated ltd, travelmania ltd, apollo travel servs ltd, pauline’s travel servs ltd, discovery travel, cosmopolitan travel & tours ltd, centro latino, kingston travel & tours ltd.

Fiwibusiness is a marketing services company. The Fiwibusiness purpose is to connect Jamaican and international consumers with local businesses.

• Funeral Homes
• car and auto parts
• Travel Agency
• Taxi Service
• Medical Equipment
• Jamaican Bookstores
• Phone stores in Jamaica
• Same Day Loans in Jamaica
• cesspool cleaner
• Pizza Hut menu
• Funeral cost in Jamaica
• Cost of funeral packages in Jamaica
• Small Business Loan or Support
• JN Bank Emergency Loan
• Data recovery service Jamaica
• Pest Control
• Car Rental Services in Jamaica
• Employment Agencies in Jamaica

Businesses by Parish

• Businesses in Kingston
• Businesses in Montego Bay Jamaica
• Businesses in Portmore Jamaica
• Businesses in Spanish Town
• Businesses in Mandeville
• Businesses in Savanna la Mar
• Businesses in May Pen Clarendon

Businesses By Towns

• Nursing and Care Homes in Kingston
• Hardware Stores in Kingston
• Doctor’s office in Kingston
• Pharmacies in Kingston
• Medical Equipment in Kingston
• Beauty Salons jamaica
• Building Contractors
• locksmiths in kingston
• Water Stores in Kingston
• Business in Ocho Rios
• Massage Service in Kingston

USEFUL LINKS

• How to Jamaica
• Jamaican Businesses
• Ja Businesses by category
• Cost of living in Jamaica
• guarantor loans in Jamaica
• Ecommerce Loan Jamaica

© 2024 fiwibusiness - All Rights Reserved.

Cookies on Companies House services

We use some essential cookies to make our services work.

We'd also like to use analytics cookies so we can understand how you use our services and to make improvements.

You've accepted analytics cookies. You can change your cookie settings at any time.

You've rejected analytics cookies. You can change your cookie settings at any time.

We use cookies to make our services work and collect analytics information. To accept or reject analytics cookies, turn on JavaScript in your browser settings and reload this page.

Please press ENTER to search

CARIBBEAN TRAVEL LIMITED

Company number 07548599

• Company Overview for CARIBBEAN TRAVEL LIMITED (07548599)
• Filing history for CARIBBEAN TRAVEL LIMITED (07548599)
• People for CARIBBEAN TRAVEL LIMITED (07548599)
• More for CARIBBEAN TRAVEL LIMITED (07548599)

Last accounts made up to 31 March 2015

Nature of business (SIC)

• 79110 - Travel agency activities

These Caribbean Islands Are Hot Right Now, According to Travel Agents

The biggest booking surprise for Caribbean travel specialists has nothing to do with where their clients were going in 2024, but more to do with where they weren’t.

In an unofficial pool with a network of more than 100 Caribbean specialists, many advisors said the smaller, uncommon Caribbean islands are where their clients are swarming to lately.

To access this content, subscribe now. Choose from two tailored subscription options: Caribbean Journal Invest for comprehensive investment news or Caribbean Journal Travel Advisor for targeted content for travel agents and advisors. Subscribe today to unlock this article and receive our biweekly newsletter. Categories: Caribbean Travel Advisor , News Recent Articles

This British Virgin Islands Beach Resort Is on the Market 

Cj invest , hotels and development , listings , news.

A rare opportunity to own a beach resort in the British Virgin Islands has emerged, Caribbean Journal Invest has learned.  To access this content, subscribe now. Choose from two tailored subscription options: Caribbean Journal Invest for comprehensive investment news or […]

This BVI Resort Just Began Its Reopening 

Caribbean travel advisor , news.

The long-awaited return of one of the top resorts in the British Virgin Islands has officially begun, Caribbean Travel Advisor has learned.  To access this content, subscribe now. Choose from two tailored subscription options: Caribbean Journal Invest for comprehensive investment […]

Mexico’s New Ultra-Luxe Wellness Retreat Is Offering Agents 10 Percent Commissions 

The eight-bedroom ZihFit, a wellness-focused luxury resort in Mexico, has launched a new program for travel advisors.  To access this content, subscribe now. Choose from two tailored subscription options: Caribbean Journal Invest for comprehensive investment news or Caribbean Journal Travel […]

Frontier Airlines Just Launched a Bunch of New Caribbean Routes — and Flights Start at $59 for a Limited Time

The airline is also launching a new route from Charlotte, North Carolina.

Frontier is making it easier to jet around the Caribbean with several new routes from Puerto Rico, and is celebrating with flights starting at less than $60.

The low-cost airline is adding nonstop service between San Juan’s Luis Muñoz Marín International Airport and both Santiago de los Caballeros in the Dominican Republic and Barbados. The Dominican Republic flight will launch on June 14 and the Barbados flight will launch on July 3.

To celebrate, the airline is offering fares starting at just $59, which must be booked by 11:59 p.m. ET on Apr. 29. These discounted tickets are valid for travel on select days of the week from June 14 through Oct. 31 and exclude several blackout dates, including July 1, July 4 to 8, July 11 to 15, July 18 to 22, July 25 to 29, Sept. 3, and Oct. 11 to 14.

“As we anticipate an exciting and potentially record-breaking summer travel season, we’re thrilled to further expand our route map,” Josh Flyr, the vice president of network and operations design at Frontier Airlines, said in a statement . “More destinations served means more affordable and convenient travel options for consumers across the U.S., Caribbean and beyond.”

In addition to the Puerto Rico flights, Frontier will launch nonstop service from Charlotte Douglas International Airport to Miami International Airport on July 5. To celebrate that route, Frontier will offer flights starting at just $29 from the two cities. The same promotional parameters and blackout dates apply to this discount.

As an ultra-low cost airline, Frontier charges extra for things like seat assignments and baggage. But recently, the airline has started to offer travelers more luxury options, like introducing a new economic business class , BizFare, in February, and adding an “ UpFront Plus” option last month, which allows travelers to purchase seats in the first two rows with a blocked middle seat for added comfort.

The airline is also shifting its strategy by cutting flights to “oversaturated” vacation markets like Florida and Las Vegas and “increasing service in certain markets that are underserved and or overpriced.”

For more Travel & Leisure news, make sure to sign up for our newsletter!

Read the original article on Travel & Leisure .

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• My Account Login
• Explore content
• About the journal
• Publish with us
• Sign up for alerts
• Open access
• Published: 25 April 2024

Travel surveillance uncovers dengue virus dynamics and introductions in the Caribbean

• Emma Taylor-Salmon 1 , 2   na1 ,
• Verity Hill 2   na1 ,
• Lauren M. Paul   ORCID: orcid.org/0000-0001-5503-7570 3   na1 ,
• Robert T. Koch 2   na1 ,
• Mallery I. Breban 2 ,
• Chrispin Chaguza 2 ,
• Afeez Sodeinde 2 ,
• Joshua L. Warren 4 , 5 ,
• Sylvia Bunch 6 ,
• Natalia Cano 6 ,
• Marshall Cone 6 ,
• Sarah Eysoldt 6 ,
• Alezaundra Garcia 6 ,
• Nicadia Gilles 6 ,
• Andrew Hagy 6 ,
• Lea Heberlein 6 ,
• Rayah Jaber 6 ,
• Elizabeth Kassens 6 ,
• Pamela Colarusso 7 ,
• Amanda Davis 7 ,
• Samantha Baudin 8 ,
• Edhelene Rico 8 ,
• Álvaro Mejía-Echeverri 8 ,
• Blake Scott 9 ,
• Danielle Stanek 9 ,
• Rebecca Zimler   ORCID: orcid.org/0009-0006-4991-4016 9 ,
• Jorge L. Muñoz-Jordán 10 ,
• Gilberto A. Santiago 10 ,
• Laura E. Adams 10 ,
• Gabriela Paz-Bailey 10 ,
• Melanie Spillane 11 , 12 ,
• Volha Katebi 11 ,
• Robert Paulino-Ramírez 13 ,
• Sayira Mueses 13 ,
• Armando Peguero 13 ,
• Nelissa Sánchez 13 ,
• Francesca F. Norman   ORCID: orcid.org/0000-0003-0336-7767 14 ,
• Juan-Carlos Galán   ORCID: orcid.org/0000-0002-8447-0960 15 ,
• Ralph Huits   ORCID: orcid.org/0000-0001-8803-9468 16 ,
• Davidson H. Hamer 17 ,
• Chantal B. F. Vogels   ORCID: orcid.org/0000-0003-0027-6480 2 , 18   na2 ,
• Andrea Morrison   ORCID: orcid.org/0009-0006-8686-2841 9   na2 ,
• Scott F. Michael   ORCID: orcid.org/0000-0003-3236-2017 3   na2 &
• Nathan D. Grubaugh   ORCID: orcid.org/0000-0003-2031-1933 2 , 5 , 18 , 19   na2  

Nature Communications volume  15 , Article number:  3508 ( 2024 ) Cite this article

19 Altmetric

Metrics details

• Computational models
• Dengue virus
• Epidemiology
• Molecular evolution

Dengue is the most prevalent mosquito-borne viral disease in humans, and cases are continuing to rise globally. In particular, islands in the Caribbean have experienced more frequent outbreaks, and all four dengue virus (DENV) serotypes have been reported in the region, leading to hyperendemicity and increased rates of severe disease. However, there is significant variability regarding virus surveillance and reporting between islands, making it difficult to obtain an accurate understanding of the epidemiological patterns in the Caribbean. To investigate this, we used travel surveillance and genomic epidemiology to reconstruct outbreak dynamics, DENV serotype turnover, and patterns of spread within the region from 2009-2022. We uncovered two recent DENV-3 introductions from Asia, one of which resulted in a large outbreak in Cuba, which was previously under-reported. We also show that while outbreaks can be synchronized between islands, they are often caused by different serotypes. Our study highlights the importance of surveillance of infected travelers to provide a snapshot of local introductions and transmission in areas with limited local surveillance and suggests that the recent DENV-3 introductions may pose a major public health threat in the region.

Similar content being viewed by others

Asynchronicity of endemic and emerging mosquito-borne disease outbreaks in the Dominican Republic

Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil

Impacts of Zika emergence in Latin America on endemic dengue transmission

Introduction.

Dengue is an acute febrile illness viral infection caused by dengue virus (DENV), which is transmitted to humans through the bite of an infected Aedes mosquito 1 , 2 , 3 . There are four genetically- and antigenically-related DENV serotypes, and while infection with one serotype generally produces long-lasting homotypic immunity, it only induces short-lived heterotypic immunity, after which infection with another serotype may result in more severe disease 1 , 2 , 4 . Almost half of the world’s population lives in dengue-endemic areas, with children bearing the majority of the disease burden 5 , 6 . Dengue has evolved from a sporadic disease into a major public health threat in the Americas, with reported case numbers reaching 20 million in the last 5 years in 46 countries 7 . The Caribbean has often been a source of reintroduction and spread of all four DENV serotypes over the last thirty years 8 , 9 . Two other Aedes -borne viruses also emerged in this region: chikungunya virus in 2013 10 , 11 and Zika virus in 2016 12 , 13 . Local infectious disease surveillance and reporting is essential for public health efforts regarding outbreak response and disease mitigation; however, the control of outbreaks is challenging in low- and middle-income countries where resources are limited 14 . In addition, dengue outbreaks can overwhelm health systems, further weakening surveillance capacity - particularly in countries that may not have strong laboratory infrastructure 15 , 16 , 17 . Therefore, the areas where disease surveillance is the most needed - like the Caribbean - are often the same areas where we have limited publicly available data.

Infectious disease surveillance of travelers has been shown to supplement local surveillance in low-resource areas 18 , 19 , 20 , 21 , 22 , 23 , 24 . Infected travelers can also be sentinels for pathogen transmission in locations where outbreaks have not yet been reported 25 . For example, characterization of pathogens in infected travelers was used to reconstruct the global spread of H1N1 in 2009 26 and an unreported Zika outbreak in Cuba in 2017 18 . Utilizing traveler data could be particularly useful for supplementing surveillance in the Caribbean because of the popularity of tourism in the region 27 . In the United States, dengue is the leading cause of febrile illness among travelers returning from the Caribbean 23 , 25 , 28 , 29 , 30 . In Florida, the number of travel-associated dengue cases has increased dramatically in recent years 31 . Florida is a good sentinel for the Caribbean, due to its geographic location and high volume of travel back and forth between Florida and the islands. Therefore, we hypothesize that we can use surveillance of dengue-infected travelers diagnosed in Florida who recently returned from the Caribbean to better reconstruct DENV dynamics in the region.

In this study, we combined surveillance and sequencing of DENV from infected travelers to estimate local outbreak sizes, track serotypes, and map the patterns of lineage spread from 2009 to 2022. We determined that travel-associated infections closely mirrored local rates for countries and territories with robust local surveillance. An increase in infected travelers returning from Cuba in 2022 has previously been reported 32 , leading to the assumption of a large dengue outbreak that was not reported to Pan-American Health Organization (PAHO), the primary source for information regarding dengue spread in the Americas 7 . We used surveillance data among travelers to estimate that the 2022 outbreak in Cuba was similar in size to other large outbreaks reported in the Americas. We used serotype data to decipher inter-island differences during outbreak years. By sequencing DENV isolates from travel associated cases, we uncovered two recent DENV-3 introductions from Asia into Jamaica and Cuba, the latter of which has now been detected in several other locations in the region 33 . Overall, our study highlights the importance of dengue surveillance among travelers and genomic epidemiology in supplementing local infectious disease surveillance in resource-limited locations by elucidating DENV transmission and spread within the Caribbean.

Dengue travel cases to supplement local surveillance

Dengue incidence in the Americas rose significantly over the last four decades, reemerging as a major public health concern and culminating in ~17.5 million reported cases from 2010 to 2019 and ~20 million cases since 2019 7 . This coincided with a rapid increase in travel-associated dengue cases within the United States, especially in Florida. The Florida Department of Health (FDOH) has a robust dengue surveillance system, which captures symptomatic cases reported in patients who traveled to a dengue-endemic area within the two weeks prior to illness onset (Table  S1 ). From 2009 to 2022, the FDOH reported between 19 (in 2017) to 929 (in 2022) travel-associated dengue cases per year, for a total of 2300 cases, with the majority (1815 cases, 78.9%) occurring in travelers who recently returned from the Caribbean (Supplementary Fig.  S1 ). Overall, four countries and one US territory made up 75.6% (1737 cases) of all travel-associated dengue cases reported in Florida from 2009 to 2022: Cuba, Puerto Rico, Dominican Republic, Haiti, and Jamaica (Fig.  1 ). There is significant variability in local dengue surveillance and reporting among Caribbean countries and territories, which can impact local outbreak responses and travel advisories 34 , 35 . We hypothesize that we can address this variability by using dengue surveillance of infected travelers in Florida to detect surveillance gaps within these five Caribbean islands.

Countries and territories are listed by total number of travel cases for each inferred origin of infection based on travel history, in descending order. Only countries or territories with at least 10 associated travel infections are shown. The complete data can be found in Supplementary Table  S1 . The inset shows a map of the location of the top 5 associated country origins of travel cases reported in Florida, with the line width proportional to the number of travel cases.

To determine the extent to which travel-associated cases reported in Florida correlated with local reporting in the Caribbean, we compared local and travel-associated dengue case numbers from 2009 to 2022 (Fig.  2 ). We obtained yearly suspected and confirmed dengue cases reported by Cuba, Dominican Republic, Haiti, Jamaica, and Puerto Rico from PAHO and all reports of travel-associated dengue cases from the FDOH. First, we compared the local and travel case trends for each country or territory. We found significant positive correlations from the Dominican Republic (Pearson r  = 0.764, p  = 0.001), Jamaica ( r  = 0.960, p  < 0.001), and Puerto Rico ( r  = 0.911, p  < 0.001), but the data from Cuba ( r  = 0.496, p  = 0.070) and Haiti ( r  = −0.694, p  = 0.056) were not correlated (Fig.  2A ). We then used flight data from the United States Department of Transportation (Supplementary Fig.  S2 ) to estimate the ‘travel infection rates’ as the number of travel-associated cases per 100,000 air passenger journeys into Florida per year from each location 18 , 36 . Comparing the travel infection rates to the local rates (dengue cases per 100,000 population), we again found positive correlations from the Dominican Republic (Pearson r  = 0.750, p  = 0.002), Jamaica ( r  = 0.912, p  < 0.001), and Puerto Rico ( r  = 0.935, p  < 0.001), but not from Cuba ( r  = 0.458, p  = 0.1) and Haiti ( r  = −0.825, p  = 0.012; Fig.  2B ). The strong correlations between travel and local cases from the Dominican Republic, Jamaica, and Puerto Rico are similar to what we previously estimated for Zika 18 and others estimated for dengue 36 , reflecting the robust and consistent arbovirus surveillance systems at these locations. Notably, we found peaks of travel-associated infections from Cuba in 2022 that were not captured by the dengue case data reported by PAHO (Fig.  2A ). This increase in travel-associated cases was also seen in other parts of the world 32 . Our data also show disagreements between travel and local dengue cases in Haiti, specifically spikes in travel-associated cases in 2012 and 2018 and a spike in local cases in 2021 that were not reflected in the other data (Fig.  2A ). In fact, there are many years of missing dengue case data in the PAHO repository from Haiti, and these gaps are frequently paired with natural disasters (e.g. 2010 earthquake). Overall, we demonstrate here that dengue travel surveillance in Florida can help supplement local surveillance in the Caribbean region to infer relative local case dynamics.

A Yearly local dengue cases (left y-axis, gray shaded area) reported by PAHO and yearly travel-associated dengue cases (right y-axis, colored lines) reported by FDOH were sorted by the origin of exposure. The datasets were compared using Pearson’s correlation coefficient. There were strong positive correlations between travel and local cases for the Dominican Republic (Pearson r  = 0.764, p  = 0.001), Jamaica ( r  = 0.960, p  < 0.001), and Puerto Rico ( r  = 0.911, p  < 0.001), with no significant correlation for Cuba ( r  = 0.498, p  = 0.070) and a negative correlation for Haiti ( r  = −0.694, p  = 0.056). B The local dengue virus incidence rates for each country or territory were calculated by the number of locally reported cases per month per 100,000 population. The travel dengue virus incidence rates for each country or territory of presumed exposure were calculated by the number of travel-associated cases per month per 100,000 air passenger journeys entering Florida from endemic locations. Colored lines represent a two-sided linear regression model with local infection rate as the predictor variable and travel infection rate as the outcome variable. Gray shaded area represents standard error. There were strong positive correlations between travel and local incidence for the Dominican Republic (Pearson r  = 0.750, p  = 0.002), Jamaica ( r  = 0.912, p  < 0.001), and Puerto Rico ( r  = 0.935, p  < 0.001), with no significant correlation for Cuba ( r  = 0.458, p  = 0.100) and a negative correlation for Haiti ( r  = −0.825, p  = 0.012). The negative correlation between the local and travel infection rates may have been driven by a decreased travel volume to Florida from 2020 to 2022 (Supplementary Fig.  S2 ).

Estimating local dengue infection rates using travelers

Having demonstrated that the Dominican Republic, Jamaica, and Puerto Rico have significant positive correlations between local and travel-associated dengue infection rates (travel cases per 100,000 air passenger journeys; Fig.  2 ), we then created a negative binomial regression model using these relationships to estimate local infection rates from Cuba and Haiti. We estimate that the 2022 dengue outbreak in Cuba is larger than any detected on the island since at least 2010 and similar in size to other large outbreaks found throughout the Americas (Fig.  3 ).

A Local and travel-associated dengue infection rates from the Dominican Republic, Jamaica, and Puerto Rico were used as predictors in a negative binomial regression model due to the strong correlations between local and travel-associated cases. The red lines indicate the predicted mean infection rates, and the shaded area indicates the 95% confidence interval, while the gray lines indicate the local dengue cases as reported to PAHO. B Local dengue infection rates in Cuba and Haiti from 2009 to 2022 were predicted using the model from panel A . The colored lines indicate the predicted mean infection rates, and the shaded area indicates the 95% prediction interval, while the gray lines indicate the local dengue cases as reported to PAHO. C Observed and predicted local infection rates for South American and Caribbean countries and territories with populations over one million inhabitants from 2009 to 2023. Within each box, thick vertical lines denote median values (50 th percentile); boxes extend from the 25 th to the 75 th percentile; horizontal lines extending from boxes denote mark the 5 th and 95 th percentiles, and the dots denote outliers, representing large outbreaks from any year. Locations in gray with observed cases were not included in our model.

In areas with inadequate local case reporting, previous studies suggested that sentinel surveillance of infected travelers can be used to estimate virus transmission dynamics and spread from endemic locations 18 , 26 , 36 . Only 3036 laboratory-confirmed dengue cases were reported by Cuba in 2022, similar to what was reported in 2019 7 . This is inconsistent with the number of cases we detected from Cuba using travel surveillance (Figs.  1 and 2A ). Moreover, dengue case data from Haiti were not reported to PAHO for 2009–2011, 2014, and 2016–2017 7 . To estimate the number of cases that likely went under-reported in Cuba and Haiti during our study period, we constructed a negative binomial regression model to predict local infection rates from the travel rates (Fig.  3A ). We found that when controlling for the gross domestic product (GDP; a relative approximation of resources available for surveillance), population, and year, the risk associated with local cases of dengue increases by 96% (95% confidence interval [CI]: 63–134%) for every one unit increase in the log of travel infection rates from the Dominican Republic, Jamaica, and Puerto Rico.

When applying our model to travel data from Cuba and Haiti, we estimate new dengue case dynamics (Fig.  3B ) and compare the predicted infection rates to other observed rates throughout the Americas (Fig.  3C ). We estimate that the average yearly dengue infection rates from Haiti (244 [95% CI: 138–434]/100,000 population) are similar to the reported and estimated rates from the Dominican Republic (188 [95% CI: 111–320]/100,000), which is reasonable given that they are on the same island. We also estimate that from 2010-2021, the peaks in dengue infection rates from Cuba were similar in magnitude to other Caribbean islands (~500/100,000 population). However, we predict that Cuba likely experienced a large outbreak in 2022 (~1000 [95% CI: 306–4117]/100,000 population), potentially one of the largest in the region. Our reconstructed dengue infection rates using travel surveillance provide a clearer picture of dynamics in the Caribbean and allow us to investigate previously unreported trends.

Asynchrony of dengue virus serotypes across locations

Using travel-associated dengue cases, we reconstructed the infection trends in different locations of the Caribbean (Fig.  3 ). To obtain a deeper resolution of the outbreaks, we determined the DENV serotype from infected individuals with recent travel to the Caribbean and estimated the annual proportions from each location from 2010 to 2022. We discovered that outbreaks on different islands were often caused by different serotypes, even when those outbreaks occurred during the same years (Fig.  4 ).

A Yearly travel-associated dengue cases by serotype were reported by FDOH and sorted by country or territory of likely exposure. B The relative proportions of yearly travel-associated dengue cases by serotype per year and per country or territory of likely exposure, normalized to account for the number of infected travelers.

While some countries report DENV serotype data associated with cases to PAHO, the data are released to the public as a binomial (present or absent) without accompanying proportions. Therefore, it is often difficult to determine (1) which serotypes are mostly responsible for outbreaks and (2) the temporal trends that may be useful for forecasting. To overcome this data limitation, we determined the serotype data for all travel-associated dengue cases from the FDOH from 2010 to 2022 (2009 serotype data were not available; Fig.  4 ; Supplementary Table  S1 ). We analyzed the data as the total number of travel cases by serotype (Fig.  4A ) and the proportion of each serotype (Fig.  4B ) per year and country or territory. As a form of validation, our serotype proportions estimated from infected travelers returning from Puerto Rico generally match the proportions from local cases reported from Puerto Rico, including the dominance of DENV-1 from 2010 to 2013, the rise in DENV-4 from 2012 to 2014, the rise of DENV-2 from 2014 to 2015, and the re-emergence of DENV-1 in 2020 37 . Overall, we found multiple serotypes for several years and locations, which has often been reported, but years with high travel infection rates were typically dominated by a single serotype (e.g. DENV-3 from Cuba in 2022 and DENV-1 from the Dominican Republic in 2019).

As is expected for DENV, we found that different serotypes transitioned in and out of dominance in each location during the twelve years (Fig.  4 ). This is consistent with genotype replacement events, which occur when a previously dominant lineage is replaced by another related, but distinct, lineage 38 , 39 , 40 . Various theories have been proposed to explain these events, including natural selection, immune pressure, and population bottlenecks. During the earlier years, however, we did detect some patterns. We found that from 2010 to 2016, DENV-1 and DENV-2 predominated in the Dominican Republic, Haiti, Jamaica, and Puerto Rico. Immediately following the 2015-2016 Zika epidemic, dengue cases decreased throughout the Americas 41 . As dengue cases began to increase again to record highs in 2019 (>3 million cases reported to PAHO), we found that many outbreaks were caused by different serotypes. The most prevalent serotypes in 2019 were DENV-1 from the Dominican Republic (96%, n  = 25) and Haiti (88%, n  = 8), DENV-2 from Cuba (90%, n  = 213), and DENV-3 from Jamaica (87%, n  = 23). By 2022, DENV-1 was the most commonly detected serotype in Puerto Rico (100%, n  = 6), DENV-2 arose in the Dominican Republic (90%, n  = 10), and DENV-3 became the new dominant serotype in Cuba (74%, n  = 735). The only location that consistently did not follow other Caribbean serotype trends, even before the Zika epidemic, was Cuba. Overall, we demonstrate that dengue outbreaks in the Caribbean cannot be treated as a single entity, even when they are synchronized throughout the region (e.g. 2019), as transmission in different islands can be due to different DENV serotypes regardless of temporal relationships.

Sequencing travel infections reveals dengue virus diversity in the Caribbean

Our analyses show that dengue outbreaks in the Caribbean exhibit serotype variability between islands despite temporal synchrony (Fig.  4 ). While serotype-level data can provide broad-scale information, there is substantial within-serotype diversity. Therefore, to uncover the DENV genetic diversity and patterns of spread within the Caribbean, we sequenced 295 traveler infections (Fig.  5 ).

Time-resolved phylogenies of each serotype, with the branches and tips colored by inferred and sampled locations respectively. Larger dots represent those DENV samples sequenced for this study.

Using sequencing data that we generated from travel-associated dengue cases, we performed four discrete phylogeographic analyses, one for each serotype (Fig.  5 ). The travel origin location in our analysis was designated as the site of presumed DENV exposure. We subdivided the Caribbean into Cuba, Dominican Republic, Haiti, Jamaica, Puerto Rico, and “other Caribbean”. For context, we used genomic data from North America, South America, and Central America, and representative DENV sequences sorted by WHO regions for the other areas of the world to highlight viral transmission into and within the Caribbean. Our data revealed the continued circulation of all four DENV serotypes and multiple clades within those serotypes in different parts of the Caribbean as recently as 2022. While most of the sequenced travel infections cluster within clades that have historically circulated within their respective regions, we also detected several introductions of all four serotypes into the Caribbean from southeast Asia, the western Pacific, and elsewhere from the Americas stretching back to the 1970s to as recently as 2021 (described in more detail in the next section; Fig.  6 ).

A Time-revolved phylogeny showing global spread of DENV-3 genotype III. The times of the most common ancestor of the clades are taken conservatively as introduction times, with 95% HPDs indicated in parentheses, and are indicated by circles. The map shows the transitions from Southeast Asia to Cuba and Jamaica and within the Caribbean. Countries or territories involved are indicated on the map, and virus transitions are indicated by lines going counter-clockwise, with thickness indicating a number of movements. B Time-resolved phylogeny shows two co-circulating DENV-2 (genotype III) clades in Cuba, which are colored in red, with 95% HPDs indicated in parentheses. The bar chart shows the frequencies of each clade in 2019 and 2022.

To support our phylogenetic analyses, we performed three independent validations. One of our primary findings is the detection of a large DENV-3 (genotype III) clade from infected travelers returning from Cuba (Figs.  5 and 6A ). First, we sequenced two samples from DENV-infected travelers returning from Cuba to Spain in 2022 and, second, we obtained sequencing data generated by the CDC Dengue Branch from travelers infected in Cuba in 2022, also provided by the FDOH. All of these sequences clustered in the same clade with the rest of the sequences from Cuba travelers. Third, we also sequenced samples from local dengue cases from the Dominican Republic collected in 2022 and found that these DENV-2 sequences clustered with DENV-2 sequences from Dominican Republic travel-associated dengue cases. These data suggest that our DENV genetic clustering patterns are not unique to our study population and sequencing methods, and likely represent local diversity.

Phylogenetic patterns of emergence, spread, and transmission

Our analyses show that infected travelers can reveal DENV diversity within the Caribbean (Fig.  5 ). We next used our genomic data to uncover patterns of DENV introductions, spread, and transmission in the region (Fig.  6 ). Our intent here is not to explore every location-specific detail, but to showcase what is possible with even a relatively limited number of sequenced DENV genomes from travelers.

In our analysis, we detected a substantial number of travel-associated dengue cases coming from Cuba during 2022 (Fig.  2 ), and we estimated that these stemmed from a large, under-reported local outbreak (Fig.  3 ) predominantly caused by DENV-3, genotype III (Figs.  4 and 5 ). Our phylogeographic analysis further shows that the large cluster of DENV-3 sequences from Cuba in 2022 (148 Cuban sequences out of 150 total sequences in the clade, posterior support for location = 1.0) was from an introduction directly or indirectly from southeast Asia that occurred by at least late 2020 (95% HPD = 2020-04-06 to 2021-05-13; Fig.  6A ). We and others found that this lineage has already spread to Puerto Rico, Florida, Arizona, and Brazil by 2022 33 , 42 . Thus, this may be a rapidly spreading lineage of concern for the Americas.

We discovered that the 2022 Cuba outbreak clade was not the first recent reintroduction of DENV-3, genotype III, into the Caribbean from southeast Asia. Sequencing travel-associated infections also revealed an earlier but distinct introduction of this genotype into Jamaica (all 11 sequences in the clade, posterior support for location = 1.0) by at least 2014 (95% HPD = 2013-02-02 to 2015-09-04; Fig.  6A ). We first detected this lineage from three travelers returning from Jamaica in 2016 and then again from 7 travelers during the re-emergence of DENV-3 in Jamaica in 2019 (Fig.  4 ). We last sequenced this lineage from a traveler from St. Lucia in late 2020, indicating that the virus had limited spread, but likely not as extensively as the Cuba lineage.

In addition to lineage introductions, we also explored within-location lineage dynamics. In particular, we detected instances of multiple lineages from the same serotype co-circulating in the same country. For example, we detected two co-circulating lineages of DENV-2 (genotype III) in Cuba, designated here as clades A and B (Fig.  6B ). We estimate that they were introduced into Cuba by at least 2016 (95% HPD 2015-12-20 to 2016-12-15, likely from Puerto Rico, posterior support = 0.77) and late 2017 (95% HPD 2017-02-20 to 2018-06-25, likely from Central America or Mexico, posterior support = 1.0), respectively, and both continued to circulate through the 2019 and 2022 outbreaks. Their relative frequencies changed between 2019 and 2022, with clade B dominating in 2019 but clade A increasing to become more even in frequency in 2022, though these trends may be impacted by sampling biases. We also found evidence of co-circulating DENV-1 clades in Cuba (Fig.  5 ). While neither of these clades has any concerning mutational signals, evaluating the transmissibility of co-circulating lineages is the basis of discovering meaningful phenotypes that may impact the effectiveness of interventions.

Travel surveillance and genomic epidemiology uncover dengue virus dynamics

Using patterns of infected travelers and virus genomics, we discovered previously unrecognized DENV dynamics within the Caribbean. Dengue is a major public health concern within the Caribbean, and the past two decades have seen significant increases in morbidity and mortality in the region 5 , 34 , 43 . With dengue outbreaks increasing in frequency and severity 43 , accurate and detailed surveillance data are crucial for epidemiological investigations. Currently, the main source of information about dengue outbreaks in the Caribbean comes from PAHO and other public health organizations, which rely on accurate case reporting from national or territorial health agencies. However, previous studies have shown large differences between case reporting to PAHO and estimated cases 34 .

Dengue surveillance among travelers can be an effective method to supplement local surveillance, especially in resource-limited settings 18 , 19 , 20 , 32 . There is a large volume of travel between Florida and the Caribbean (Supplementary Fig.  S2 ), and Florida has experienced a steady increase in imported dengue cases over the last two decades, especially from the Caribbean (Fig.  1 ) 44 . In this study, we investigated whether travelers with dengue returning to Florida could be used as a surrogate for local transmission in the Caribbean and found significant positive correlations between local and travel infection rates for the Dominican Republic, Jamaica, and Puerto Rico (Fig.  2B ). For locations with local surveillance gaps, we built a model to estimate local infection rates in these areas, assuming the similarity between local and travel data (Fig.  3 ). From this analysis, we uncovered a large dengue outbreak in Cuba in 2022 (Fig.  3B ) and estimated that it was similar in size to other large outbreaks detected elsewhere in the Americas (Fig.  3C ). To investigate the DENV serotypes responsible for these outbreaks, we analyzed serotype data from infected travelers returning to Florida and showed that these outbreaks are not synchronized across islands, with different serotypes responsible for outbreaks on different islands within the same year (Fig.  4 ). We then used viral genomics to provide a snapshot of genetic diversity within the region (Fig.  5 ) and uncover DENV spread and introductions (Fig.  6 ). Overall, we demonstrate that using information about dengue in travelers, including the use of sequencing, should become more routinely used to enhance dengue surveillance.

New DENV-3 introductions from Asia led to a large outbreak in Cuba

There have been several reintroductions of all four DENV serotypes into the Americas since its reemergence during the 1960–80s. Here, we detected two recent DENV-3 (genotype III) introductions into Cuba and Jamaica. We estimate that the introduction from southeast Asia into Cuba occurred by late 2020 (Fig.  6A ) and, in the course of only two years, caused a large outbreak (Fig.  3B ) and spread to several other locations in the Americas 33 . Given the speed of these events, it is possible that this DENV-3 lineage has a transmission advantage over at least some DENV lineages in the Americas.

This is not the first time that DENV-3 re-emerged in the Americas leading to widespread outbreaks. Historically, DENV-3 was re-introduced in the Americas in the 1970s, but then was not detected for 16 years between 1978 and 1994, when it was almost simultaneously isolated from Nicaragua and Panama 45 , 46 , 47 . It subsequently spread throughout Central America and the Caribbean, leading to widespread epidemics of dengue hemorrhagic fever 45 , 47 , 48 , 49 . DENV immune waning has previously been observed 4 , 50 , 51 , 52 , 53 , 54 and the sudden DENV-3 re-emergence stemming from that introduction could be attributed to the loss of immunity during the 16-year hiatus, which could be similarly true for the recent DENV-3 introduction into Cuba. Outside of the two new DENV-3 introductions we detected and tracked with travelers, there was very little detection of DENV-3 in the Caribbean (Fig.  3 ) and elsewhere in the Americas over the past 10 years 33 , 55 , 56 . While we do not yet know the true epidemiological impact of this newly introduced lineage, this will be important to closely monitor through local and travel surveillance.

Interestingly, the DENV-3 introduction into Jamaica has not spread to the same extent as the introduction into Cuba, despite its introduction almost 6 years earlier (Fig.  6A ). It could indicate that there are notable transmissibility differences between the two lineages or that the Jamaican lineage did not become established within a population with sufficient susceptibility or mobility to facilitate its spread. While these deterministic and stochastic processes require further investigation, even knowing that this introduction occurred was only possible through our surveillance among travelers - this clade was entirely sequenced from travelers (Fig.  6A ).

Genetic diversity within the region

By sequencing DENV genomes from infected Caribbean travelers, we demonstrated widespread diversity of circulating viral lineages, both between and within serotypes (Figs.  4 and 5 ). Even in outbreak years, such as 2019 or 2022, there was not one lineage that became dominant in the region; instead, different serotypes were often responsible for outbreaks on different islands, even if they occurred at the same time (Fig.  4 ). This indicates synchronized outbreaks are more likely driven by population (e.g. time since last outbreak) and environmental effects (e.g. El Niño years) than virus-related factors.

Most dengue-endemic areas in the Americas have co-circulation of multiple serotypes, which increases the likelihood of concurrent infections 57 , 58 , 59 . In fact, the first-ever confirmed case of concurrent DENV infection was reported in Puerto Rico during the 1982 outbreak in a patient infected with DENV-1 and -4 serotypes 58 , 60 . However, we noted minimal numbers of mixed infections when reviewing serotype data (14 out of 1328, Fig.  4 ), which is significantly lower than those previously reported 57 . Given the size of our dataset, it is possible that the overall likelihood of concurrent infections, even in hyperendemic locations, is actually quite small, as is their overall impact on severe dengue cases and epidemics.

Limitations

Travel surveillance data is limited by location-specific patterns and volumes of travel 19 , 25 . During our study period, there were years in which we detected minimal or no infected travelers despite local dengue cases being reported to PAHO (Fig.  2A ). This introduced biases in our local case estimates (Fig.  3 ) and in our patterns of DENV emergence and spread throughout the region (Fig.  6 ), as we have no travel data from that time period.

For this study, we assumed that the risk of DENV infection was similar for travelers and local inhabitants in endemic countries and territories, meaning that a rise in local cases would correspond to a relative increase in travel-associated infections. However, this may not be the case and would depend on the travelers’ previous exposure to dengue and related flavivirus infections or vaccinations, as well as on the general patterns of travelers’ behaviors while visiting the country or territories (e.g. DENV infections are more common among individuals visiting their friends and relatives than people traveling for other reasons). Endemic locations also experience heterogeneity with regard to dengue risk, as the primary vector for dengue in the Caribbean is Aedes aegypti , which is found more commonly in urban areas. It is also possible that some residents in endemic locations would be less likely to seek medical care and thus be diagnosed with only mild dengue symptoms, as the illness is a common occurrence for them. Thus, using travelers as sentinels alone cannot provide a complete picture of local dengue outbreaks.

Calculating travel infection rates from Cuba has important limitations we tried to address during our analysis. First, due to the associations between local dengue outbreaks in Florida and infected travelers from Cuba, the FDOH enhanced its case finding among individuals reporting recent travel from this location. The enhanced case finding was particularly apparent in 2019 and 2022, when the FDOH reported 413 and 929 travel-associated dengue cases from Cuba, respectively. We attempted to correct this by only using cases in our calculations that would have been detected in those years using the standard practice (i.e. not using “travel to Cuba” as the reason for DENV testing since that is not common practice for travel from other locations). In addition, there was also difficulty with ascertaining an accurate number of travelers from Cuba to Florida, as not all travel between these two areas is documented, including boat travel. We do not expect this to significantly impact our travel volume estimates as we previously thoroughly investigated travel patterns from Cuba to Florida 18 , and undocumented boat travel is estimated to be only 1.18% (6,182/524,611 in 2022) of the travel volumes (air passenger journeys) that we obtained from the US Department of Transportation 61 . The COVID-19 pandemic also impacted travel throughout the region (Supplementary Fig.  S2 ) and could have impacted how people interacted with the medical system (e.g. avoiding hospitals, fevers presumed secondary to SARS-CoV-2). This makes it difficult to interpret data from 2020, 2021, and, to some extent, 2022, although for that last year, travel restrictions were mostly lifted, and we detected increased travel within the region (Supplementary Fig.  S2 ). Thus, the potential inaccuracies in our travel infection rates from Cuba mean that our modeled local estimates should be viewed as relative rates rather than as absolute values. The compilation of our analysis still indicates that there was a large under-reported dengue outbreak in Cuba in 2022, a finding that was independently discovered from travelers returning from Cuba to other locations 32 .

Utilizing infected travelers as a means of detecting local outbreaks should not replace local dengue surveillance; however, it can be helpful for locations where local surveillance is not feasible or is underfunded. By supplementing local data, travel surveillance can assist with detecting local outbreaks and estimating their size. When combined with genomic epidemiology, we used travel surveillance to provide a snapshot of the diversity of DENV within the Caribbean, as well as reveal patterns of DENV emergence and lineage spread. While we did not address it in this study, travel surveillance can also provide important epidemiological information at the destination (Florida, in this case) and could be incorporated into forecasting models. If this framework was incorporated into a routine system, utilizing networks such as GeoSentinel, over time, it would help support global surveillance efforts to combat the surge of dengue.

The Institutional Review Boards (IRB) from the FDOH, Universidad Iberoamerican (UNIBE), Florida Gulf Coast University, and the Yale University Human Research Protection Program determined that pathogen genomic sequencing of de-identified remnant diagnostic samples as conducted in this study is not research involving human subjects (Yale IRB Protocol ID: 2000033281; UNIBE-CEI# 2021-88).

Travel-associated cases, serotypes, and infection rates

Weekly cumulative reports on travel-associated dengue case numbers were collected from 2009 to 2022 and are publicly available from the FDOH 62 . These cases reported on the FDOH database include those that were confirmed by both PCR and serologic assays. Serotype data for travel-associated dengue cases was determined by the FDOH using the CDC DENV-1–4 RT-PCR Assay 63 . Travel-associated cases occurred in individuals who had traveled to a dengue-endemic country or territory in the two weeks prior to symptom onset. For this study, we only included patients who traveled to one endemic location within the 2 weeks prior to symptoms onset so we could more accurately sort the temporal and spatial distribution of travel-associated cases. This led to the exclusion of 28 patients who traveled to multiple countries during our study period, constituting 1.2% of the 2300 total cases (Supplementary Table  S1 ). Within the Caribbean, the focus of this paper, there were 18 patients that were excluded due to traveling to multiple countries, constituting 1% of the 1815 total cases. Therefore, due to the small number of these cases, we did not feel that excluding them would affect our analysis. We aggregated the data by year and by location of likely exposure (i.e., travel origin).

Dengue is a reportable disease in the United States. In addition to health care provider and laboratory reporting, the FDOH uses syndromic surveillance to aid in case identification. FDOH detected syndromic surveillance cases by searching de-identified chief complaints, admission and discharge diagnoses, travel-related fields, etc., obtained from participating emergency rooms and urgent care centers in Florida. Information from suspected dengue cases are forwarded to the county health departments, who in turn reach out to the local hospitals and ascertain whether dengue testing was ordered. Enhanced surveillance was increased during 2019 and 2022 due to the large number of travel-associated cases being detected. These efforts involved adding recent travel to Cuba as a criterion, in addition to dengue-like symptoms. Eighteen of the 413 travel-associated cases in 2019 and 397 of the 929 cases in 2022 were first identified via syndromic surveillance and used in our analysis. Of note, 116 cases identified via enhanced surveillance in 2022 would not have met our case definition without this additional criterion. Therefore, in order to counter these differences in case ascertainment, we only included cases captured via traditional reporting, not enhanced detection of cases among travelers returning from Cuba, for our calculations.

When we compared the local and travel case trends for Cuba with versus without the enhanced surveillance, we found that excluding these travel cases led to decreased correlation (Pearson r  = 0.575, p  = 0.032 versus r  = 0.496, p  = 0.070, respectively). When we compared the travel and local infection rates for Cuba with versus without the enhanced surveillance, we once again found that case exclusion led to decreased correlation (Pearson r  = 0.516, p  = 0.059 versus r  = 0.458, p  = 0.1, respectively). Therefore, we determined that including all the data would increase our estimates of the outbreak sizes in Cuba, and chose to use only cases captured by traditional reporting to not overestimate these local outbreaks.

Yearly travel infection rates from all exposure (origin) and reporting (destination) combinations were calculated by the number of travel-associated cases per 100,000 airline passenger journeys (from origin to destination/year). Exposure-reporting combinations that accounted for less than 80 imported cases were not included in this analysis; therefore, only data from Cuba, Dominican Republic, Haiti, Jamaica, and Puerto Rico are included. Air travel data were obtained as detailed below.

Air passenger volumes

We collected air passenger volumes to calculate dengue travel infection rates. We obtained the number of passengers traveling by air from Cuba, the Dominican Republic, Haiti, Jamaica, and Puerto Rico that disembarked in the US port of entry in Florida from 2009 to 2022 as international and domestic non-stop segment traffic reports (T100) from the Office of Data, Analytics, and Technology (DAT), Division of Global Migration Health (DGMH). The flight travel volume data were provided by OAG Aviation Worldwide Ltd. OAG DOT Analyser, T100 International and Domestic Segment Traffic Reports, Version 2.6.1 2023 ( https://analytics.oag.com/analyser-client/home ; accessed May 16, 2023). United States Department of Transportation (DOT) data includes all commercial chartered and military flights arriving in airports in the United States and includes origin and destination. One limitation of DOT data is that it does not include connecting flight information. However, as this would lead to a potential over-estimation of total travelers and, therefore, potentially an under-estimation of travel infection rates, we felt this was reasonable.

Cruise and boat travel data were not included. There were very few infections linked with boat travel in our dataset, even between Cuba and Florida. There were also very few infections linked to cruise travel. It may be that these cases are more likely to be tourists who are subsequently diagnosed elsewhere (and just visiting Florida for the cruise departure) or that they may have different risk behaviors compared to air travelers.

Local cases and infection rates

PAHO is the primary source for information regarding dengue spread in the Americas, with data on suspected and confirmed cases for countries and territories within the Americas with local transmission 7 . We obtained yearly dengue case counts in Cuba, Dominican Republic, Haiti, Jamaica, and Puerto Rico from 2009 to 2022, as well as local dengue infection rates (suspected and confirmed dengue cases per 100,000 population). Infection rates were used as an estimate for infection likelihood to investigate sources of dengue introductions.

Estimated local dengue cases

We constructed a negative binomial regression model to predict local infection rates from the travel infection rates due to evidence of overdispersion in the initial Poisson regression model that was tested using the performance package in R . Our final model can be seen below:

Where \({Y}_{t}\) is the number of cases at time period t , r is a measure of overdispersion in the data and \({\lambda }_{t}\) is the expected number of cases at time period t . In the regression equation, \({{pop}}_{t}\) is the country population at time t as an offset term for expected number cases to get an infection rate. We used two data types: locally acquired dengue cases by country and travel-associated dengue cases by country of origin to inform estimates of local infection rates in Cuba and Haiti on a scale comparable to local infections in the other three locations. A logarithmic relationship between travel and local infection rates was specified to account for high travel infections ( \({Travel\; Infection\; Rate}\) ), particularly in Cuba. The value of 0.02 was added to avoid computational problems when travel infection rates equaled 0 and was selected via sensitivity analysis (lowest AIC score). Because we theorized that countries and territories with a higher GDP (obtained from https://worldpopulationreview.com/countries ) would be able to devote more resources to finding and reporting local dengue cases, we created the variable \({GDPcat}\) by income, with lower-middle as GDP <$12,535 and upper as >$12,535. This ultimately placed Puerto Rico in the upper category and stratified the other four countries in the lower category. To account for the temporal trend in the outcome, we included a \({Year}\) as a linear predictor in the model. We tested for autocorrelation in Puerto Rico, Jamaica, and the Dominican Republic separately using the Durbin–Watson test and found no significant autocorrelation ( p  = 0.90, 0.91, and 0.89, respectively). In addition, we tested a mixed model allowing for a country- or territory-specific random GDP effect that ultimately performed worse (AIC 752 compared to 749 for the fixed model) R code and data are available at: https://github.com/grubaughlab/2023_paper_DENV-travelers

Dengue virus sequencing

Patient serum samples were selected for study inclusion according to Ct values from prior FDOH Trioplex and serotype-specific PCR diagnostics and/or volume availability. In general, samples with a Ct value < 35 were aliquoted to provide 160 µL per sample. Lesser volume samples were included if Ct value < 25. All samples were de-identified to maintain patient privacy and blind the study.

140 µL or less of each sample was manually extracted using the QIAamp Viral RNA Mini Kit (Qiagen, Germantown, MD) following the protocol outlined in the manual unless otherwise specified. Linear acrylamide (Invitrogen by Thermo Fisher Scientific, Waltham, MA) was substituted, 1 µL of 5 mg/mL per sample, in place of the kit provided carrier RNA. Each sample was eluted in 60 µL of ultrapure, nuclease-free water (Invitrogen by Thermo Fisher Scientific, Waltham, MA) and stored at −80 °C. Sample extracts were kept frozen on dry ice during transport and shipped to collaborators for subsequent sequencing.

Dengue virus RNA was sequenced using a pan-serotype, highly multiplexed PCR approach called ‘DengueSeq’ (a derivative of PrimalSeq 64 ). A detailed protocol, including the DENV1-4 primer schemes, is available 65 , 66 . In brief, we prepared libraries using the Illumina COVIDSeq test (RUO version) with the DENV1-4 primers, and pooled libraries were sequenced on the Illumina NovaSeq (paired-end 150), targeting 1 million reads per individual library. Consensus genomes were generated at a depth of coverage of 20X and a minimum frequency threshold of 0.75 using our DengueSeq bioinformatics pipeline 67 , which includes iVar 68 . All DENV genomes and sequencing data are available on BioProject PRJNA951702.

Phylogenetic analyses

To account for differences in sampling intensity globally and to highlight dynamics within the Caribbean; we performed sample selection on the global background dataset. We used all sequences sampled from the Caribbean and then took up to 10 sequences per country or territory per year per serotype, with a strict coverage cut-off applied to all sequences of 70% of genome coverage. We then aligned these sequences with MAFFT v.7.490 69 and manually curated them using Geneious v 2022.1.1 ( https://www.geneious.com ). We generated an initial Maximum Likelihood (ML) tree for each serotype separately using the HKY substitution model 70 in IQTree v2.1.4 71 . We put this ML tree into TempEST 72 to assess the molecular clock signal and to identify molecular clock outliers, which were then removed 72 . Any remaining sylvatic sequences were also removed. The final dataset sizes therefore were DENV-1 n  = 1095, DENV-2 n  = 1406, DENV-3 n  = 839, and DENV-4 n  = 345.

In the interests of computational efficiency, we split the analysis into topology estimation and phylogeographic inference. We began by estimating the topology in BEAST v1.10.5 73 using a generalized time reversible (GTR) model 74 , a gamma rate heterogeneity model with four categories 75 , and a relaxed molecular clock 75 as in ref. 41 . The mean clock rate of each tree, using a CTMC scale prior on the mean and an exponential prior on the standard deviation, and their 95% HPDs are: 6.61 × 10 −4 (5.81 × 10 −4 to 6.41 × 10 −4 ), 8.20 × 10 −4 (7.78 × 10 −4 to 8.65 × 10 −4 ), 6.69 × 10 −4 (6.28 × 10 −4 to 7.05 × 10 −4 ) and 7.68 × 10 −4 (6.34 × 10 −4 to 8.94 ×10 −4 ) substitutions/site/year for DENV-1 to -4, respectively.

We used a Skygrid coalescent model 76 with a Hamiltonian Monte Carlo (HMC) operator 77 . We defined the gridpoints for effective population size estimation externally to be at the start of each year, every year until 2000, and then every 25 years until 1900 for DENV-1 and DENV-3, and every 50 years until 1710 for DENV-2 and every 50 years until 1750 for DENV-4. These gridpoints aimed to balance resolution in more recent years against computational efficiency, and final dates were placed slightly before the estimated roots of the trees, as described in 78 .

The length and number of chains required for convergence and sufficient ESS values depended on the serotype but ranged between two and four chains of 100–600 m states with 10–60% removed for burn-in.

From each of these analyses, we randomly sampled 500 trees from the post-burn-in posterior distribution to use as an empirical tree distribution to infer the geographic spread of each dengue virus serotype. We grouped together locations of sequences, starting with WHO regions (Africa, Europe, eastern Mediterranean, Southeast Asia, and western Pacific). The Americas were further split into South America, Central America plus Mexico, and the rest of North America. We also split the Caribbean into Jamaica, Haiti, Cuba, Dominican Republic, Puerto Rico, and other Caribbean. In total, there were 14 regions for DENV-1 and DENV-2, 12 for DENV-4, and 10 for DENV-3. Details of the number of sequences for each region can be found in Supplementary Table  S1 . We performed a discrete asymmetric phylogeographic analysis using these regions and a CTMC prior 79 . Each serotype analysis was run for two chains of 10 m states, each with 10% removed for burn-in. Assessment of convergence for every analysis was performed using Tracer 78 .

Introductions were inferred using a custom Python script. We defined an introduction as the oldest node on a branch which transitioned into the territory/region of interest and counted all downstream nodes as part of the same introduction regardless of further exports/reintroductions. The time of introduction was taken conservatively, as the time of the transition node itself, and should be interpreted as the latest approximate time that the introduction could have occurred (i.e. the introduction could have occurred earlier, but not later). The XML files are available at: https://github.com/grubaughlab/2023_paper_DENV-travelers .

Reporting summary

Further information on research design is available in the  Nature Portfolio Reporting Summary linked to this article.

Data availability

All DENV genomes and sequencing data generated in this study are available on BioProject PRJNA951702. Alignments provided in our data repository include all GenBank accession numbers for any publicly available sequences that were analyzed in this study ( https://github.com/grubaughlab/2023_paper_DENV-travelers ). The travel surveillance data is available in the Supplementary Information file. The air passenger data used in this study are proprietary and were purchased from OAG Aviation Worldwide Ltd. These data were used under the United States Centers for Disease Control and Prevention license for the current study, and so are not publicly available. The authors are available to share the air passenger data upon request and with the permission of OAG Aviation Worldwide Ltd.

Code availability

All code and model results are available at: https://github.com/grubaughlab/2023_paper_DENV-travelers .

Kimberlin, D. W., Barnett, E., Lynfield, R. & Sawyer, M. H. Red Book 2021: Report of the Committee on Infectious Diseases . (American Academy of Pediatrics, 2021).

Guzman, M. G. & Harris, E. Dengue. Lancet 385 , 453–465 (2015).

Article   PubMed   Google Scholar  

Bhatt, S. et al. The global distribution and burden of dengue. Nature 496 , 504–507 (2013).

Article   ADS   CAS   PubMed   PubMed Central   Google Scholar  

Waggoner, J. J. et al. Homotypic Dengue Virus Reinfections in Nicaraguan Children. J. Infect. Dis. 214 , 986–993 (2016).

Article   PubMed   PubMed Central   Google Scholar  

Christie, C. D. C., Lue, A. M. & Melbourne-Chambers, R. H. Dengue, chikungunya and zika arbovirus infections in Caribbean children. Curr. Opin. Pediatr. 35 , 155–165 (2023).

Verhagen, L. M. & de Groot, R. Dengue in children. J. Infect. 69 , S77–S86 (2014).

PAHO. Dengue https://www3.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en.html (2022).

Brathwaite Dick, O. et al. The history of dengue outbreaks in the Americas. Am. J. Trop. Med. Hyg. 87 , 584–593 (2012).

Tapia-Conyer, R., Betancourt-Cravioto, M. & Méndez-Galván, J. Dengue: an escalating public health problem in Latin America. Paediatr. Int. Child Health 32 , 14–17 (2012).

Weaver, S. C. Arrival of chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl. Trop. Dis. 8 , e2921 (2014).

Fischer, M. & Staples, J. E., Arboviral Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013-2014. MMWR Morb. Mortal. Wkly. Rep. 63 , 500–501 (2014).

PubMed   PubMed Central   Google Scholar  

Santiago, G. A. et al. Tracing the Origin, Spread, and Molecular Evolution of Zika Virus in Puerto Rico, 2016-2017. Emerg. Infect. Dis. 27 , 2971–2973 (2021).

Article   CAS   PubMed   PubMed Central   Google Scholar  

Faria, N. R. et al. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature 546 , 406–410 (2017).

Worsley-Tonks, K. E. L. et al. Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries. Lancet Glob. Health 10 , e579–e584 (2022).

Magalhães, A. R. et al. Neglected tropical diseases risk correlates with poverty and early ecosystem destruction. Infect. Dis. Poverty 12 , 32 (2023).

Da Conceição Araújo, D. et al. Determining the association between dengue and social inequality factors in north-eastern Brazil: A spatial modelling. Geospat. Health 15 , 71–80 (2020).

do Carmo, R. F., Silva Júnior, J. V. J., Pastor, A. F. & de Souza, C. D. F. Spatiotemporal dynamics, risk areas and social determinants of dengue in Northeastern Brazil, 2014-2017: an ecological study. Infect. Dis. Poverty 9 , 153 (2020).

Grubaugh, N. D. et al. Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic. Cell 178 , 1057–1071.e11 (2019).

Leder, K. et al. Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016. PLoS One 12 , e0185689 (2017).

Wilder-Smith, A., Chang, C. R. & Leong, W. Y. Zika in travellers 1947-2017: a systematic review. J. Travel Med . 25 , tay044 (2018).

Hamer, D. H. et al. Travel-Associated Zika Virus Disease Acquired in the Americas Through February 2016: A GeoSentinel Analysis. Ann. Intern. Med. 166 , 99–108 (2017).

Harvey, K. et al. Surveillance for travel-related disease–GeoSentinel Surveillance System, United States, 1997-2011. MMWR Surveill. Summ. 62 , 1–23 (2013).

PubMed   Google Scholar  

Leder, K. et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann. Intern. Med. 158 , 456–468 (2013).

Angelo, K. M. et al. Zika among international travellers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice. J. Travel Med. 27 , taaa222 (2020).

Article   Google Scholar  

Osman, S. & Preet, R. Dengue, chikungunya and Zika in GeoSentinel surveillance of international travellers: a literature review from 1995 to 2020. J. Travel Med . 27 , taaa222 (2020).

Fraser, C. et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324 , 1557–1561 (2009).

The World Bank in the Caribbean. World Bank https://www.worldbank.org/en/country/caribbean/overview (2023).

Wilson, M. E. et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin. Infect. Dis. 44 , 1560–1568 (2007).

Fink, D., Wani, R. S. & Johnston, V. Fever in the returning traveller. BMJ 360 , j5773 (2018).

Marks, M., Johnston, V. & Brown, M. 150 - Fever in the Returned Traveler. In Hunter’s Tropical Medicine and Emerging Infectious Diseases, 10th ed. (eds Ryan, E. T., Hill, D. R., Solomon, T., Aronson, N. E. & Endy, T. P.) 1077–1086 (Elsevier, London, 2020).

Rey, J. R. Dengue in Florida (USA). Insects 5 , 991–1000 (2014).

Díaz-Menéndez, M. et al. Dengue outbreak amongst travellers returning from Cuba-GeoSentinel surveillance network, January-September 2022. J. Travel Med . 30 , taac139 (2023).

Naveca, F. G. et al. Reemergence of dengue virus serotype 3, Brazil, 2023. bioRxiv https://doi.org/10.1101/2023.05.03.23288351 (2023).

Torres, J. R., Orduna, T. A., Piña-Pozas, M., Vázquez-Vega, D. & Sarti, E. Epidemiological Characteristics of Dengue Disease in Latin America and in the Caribbean: A Systematic Review of the Literature. J. Trop. Med. 2017 , 8045435 (2017).

Gómez-Dantés, H. & Willoquet, J. R. Dengue in the Americas: challenges for prevention and control. Cad. Saude Publica 25 , S19–S31 (2009).

Gossner, C. M. et al. Dengue virus infections among European travellers, 2015 to 2019. Euro Surveill . 27 , 2001937 (2022).

Ryff, K. R. et al. Epidemiologic Trends of Dengue in U.S. Territories, 2010-2020. MMWR Surveill. Summ. 72 , 1–12 (2023).

Katzelnick, L. C. et al. Antigenic evolution of dengue viruses over 20 years. Science 374 , 999–1004 (2021).

Zhang, C. et al. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J. Virol. 79 , 15123–15130 (2005).

Adams, B. et al. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc. Natl Acad. Sci. USA 103 , 14234–14239 (2006).

Brito, A. F. et al. Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil. Nat. Commun. 12 , 2619 (2021).

Jones, F. K. et al. Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022-April 2023. Emerg. Infect. Dis . 30 , 376–379 (2024).

Santos, L. L. M. et al. Dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean: a systematic review. Rev. Panam. Salud Publica 47 , e34 (2023).

FDOH. Dengue Fever https://www.floridahealth.gov/diseases-and-conditions/dengue/ (2022).

Guzman, M. G. & Kouri, G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 27 , 1–13 (2003).

MMWR. Dengue type 3 infection—Nicaragua and Panamá, October–November, 1994 . 21–24 (MMWR, 1995).

Guzmán, M. G., Huelva, G., Saenz, E. & Quiroz, E. Reintroduccion del dengue 3 en las Americas: 1994-1996. Arch. Venez. Med. Trop. Parasitol. Med . 2 , 8–19 (1998)

Figueroa, R. & Ramos, C. Dengue virus (serotype 3) circulation in endemic countries and its reappearance in America. Arch. Med. Res. 31 , 429–430 (2000).

Article   CAS   PubMed   Google Scholar  

Briseño-García, B. et al. Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. Emerg. Infect. Dis. 2 , 133–135 (1996).

Aogo, R. A. et al. Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics. Sci. Transl. Med . 15 , eadi1734 (2023).

López, L., Paul, R. E., Cao-Lormeau, V.-M. & Rodó, X. Considering waning immunity to better explain dengue dynamics. Epidemics 41 , 100630 (2022).

Forshey, B. M., Stoddard, S. T. & Morrison, A. C. Dengue Viruses and Lifelong Immunity: Reevaluating the Conventional Wisdom. J. Infect. Dis. 214 , 979–981 (2016).

Salje, H. et al. Reconstruction of antibody dynamics and infection histories to evaluate dengue risk. Nature 557 , 719–723 (2018).

OhAinle, M. et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci. Transl. Med. 3 , 114ra128 (2011).

Santiago, G. A. et al. Reemergence and decline of dengue virus serotype 3 in Puerto Rico. J. Infect. Dis. 206 , 893–901 (2012).

L’Azou, M. et al. Dengue seroprevalence in the French West Indies: a prospective study in adult blood donors. Am. J. Trop. Med. Hyg. 92 , 1137–1140 (2015).

Loroño-Pino, M. A. et al. Common occurrence of concurrent infections by multiple dengue virus serotypes. Am. J. Trop. Med. Hyg. 61 , 725–730 (1999).

Sirisena, N. et al. Concurrent dengue infections: Epidemiology & clinical implications. Indian J. Med. Res. 154 , 669–679 (2021).

Article   PubMed Central   Google Scholar  

Andrade, E. H. P. et al. Spatial-Temporal Co-Circulation of Dengue Virus 1, 2, 3, and 4 Associated with Coinfection Cases in a Hyperendemic Area of Brazil: A 4-Week Survey. Am. J. Trop. Med. Hyg. 94 , 1080–1084 (2016).

Sharp, T. M., Ryff, K. R., Santiago, G. A., Margolis, H. S. & Waterman, S. H. Lessons Learned from Dengue Surveillance and Research, Puerto Rico, 1899-2013. Emerg. Infect. Dis. 25 , 1522–1530 (2019).

Boyette, C. US Coast Guard returns 273 migrants intercepted off Florida Coast to Cuba . (CNN, 2023).

FL DOH. Mosquito-Borne Disease Surveillance http://www.floridahealth.gov/diseases-and-conditions/mosquito-borne-diseases/surveillance.html (2022).

Santiago, G. A. et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl. Trop. Dis. 7 , e2311 (2013).

Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12 , 1261–1276 (2017).

Vogels, C. et al. DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus. protocols.io . https://www.protocols.io/view/dengueseq-a-pan-serotype-whole-genome-amplicon-seq-kqdg39xxeg25/v2 . https://doi.org/10.17504/protocols.io.kqdg39xxeg25/v1 (2022).

Vogels, C. B. F. et al. DengueSeq: A pan-serotype whole genome amplicon sequencing protocol for dengue virus. medRxiv https://doi.org/10.1101/2023.10.13.23296997 (2023).

Hill, V., Chaguza, C. & Lab, G. DENV_pipeline. https://github.com/grubaughlab/DENV_pipeline (2023).

Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20 , 8 (2019).

Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30 , 772–780 (2013).

Hasegawa, M., Kishino, H. & Yano, T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22 , 160–174 (1985).

Article   ADS   CAS   PubMed   Google Scholar  

Minh, B. Q. et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 37 , 1530–1534 (2020).

Rambaut, A., Lam, T. T., Max Carvalho, L. & Pybus, O. G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2 , vew007 (2016).

Suchard, M. A. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4 , vey016 (2018).

Tarvare, S. Some probabilistic and statistical problems in the analysis of DNA sequences. In Some mathematical question in biology-DNA sequence analysis (American Mathematical Society, 1986).

Yang, Z. Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J. Mol. Evol. 39 , 306–314 (1994).

Gill, M. S. et al. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol. Biol. Evol. 30 , 713–724 (2013).

Baele, G., Gill, M. S., Lemey, P. & Suchard, M. A. Hamiltonian Monte Carlo sampling to estimate past population dynamics using the skygrid coalescent model in a Bayesian phylogenetics framework. Wellcome Open Res. 5 , 53 (2020).

Hill, V. & Baele, G. Bayesian Estimation of Past Population Dynamics in BEAST 1.10 Using the Skygrid Coalescent Model. Mol. Biol. Evol. 36 , 2620–2628 (2019).

Ferreira, M. A. R. & Suchard, M. A. Bayesian analysis of elapsed times in continuous-time Markov chains. Can. J. Stat. 36 , 355–368 (2008).

Article   MathSciNet   Google Scholar  

Download references

Acknowledgements

We acknowledge S. Taylor and P. Jack for technical discussions. This publication was made possible by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under Award Number DP2AI176740 (NDG), CTSA Grant Number UL1 TR001863 from the National Center for Advancing Translational Science, a component of the NIH (CBFV), the NIH T32AI055403 (AS), National Science Foundation (NSF) Graduate Research Fellowship under Grant No. DGE-2139841 (AS), The Dominican Ministry of Higher Education and Technology Fund (FONDOCYT-2022-1B3-069), the National Institute of General Medical Sciences R21GM142011 (SFM), and through a Cooperative Agreement between the US Centers for Disease Control and Prevention (CDC) and the International Society of Travel Medicine (ISTM) (Federal Award Number: 1 U01CK000632-01-00). The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC, NIH, or FDOH.

Author information

These authors contributed equally: Emma Taylor-Salmon, Verity Hill, Lauren M. Paul, Robert T. Koch.

These authors jointly supervised this work: Chantal B. F. Vogels, Andrea Morrison, Scott F. Michael, Nathan D. Grubaugh.

Authors and Affiliations

Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA

Emma Taylor-Salmon

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

Emma Taylor-Salmon, Verity Hill, Robert T. Koch, Mallery I. Breban, Chrispin Chaguza, Afeez Sodeinde, Chantal B. F. Vogels & Nathan D. Grubaugh

Department of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL, USA

Lauren M. Paul & Scott F. Michael

Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA

Joshua L. Warren

Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, USA

Joshua L. Warren & Nathan D. Grubaugh

Bureau of Public Health Laboratories, Division of Disease Control and Health Protection, Florida Department of Health, Tampa, FL, USA

Sylvia Bunch, Natalia Cano, Marshall Cone, Sarah Eysoldt, Alezaundra Garcia, Nicadia Gilles, Andrew Hagy, Lea Heberlein, Rayah Jaber & Elizabeth Kassens

Bureau of Public Health Laboratories, Division of Disease Control and Health Protection, Florida Department of Health, Jacksonville, FL, USA

Pamela Colarusso & Amanda Davis

Florida Department of Health in Miami-Dade County, Miami, FL, USA

Samantha Baudin, Edhelene Rico & Álvaro Mejía-Echeverri

Bureau of Epidemiology, Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, FL, USA

Blake Scott, Danielle Stanek, Rebecca Zimler & Andrea Morrison

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico

Jorge L. Muñoz-Jordán, Gilberto A. Santiago, Laura E. Adams & Gabriela Paz-Bailey

Office of Data, Analytics, and Technology, Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

Melanie Spillane & Volha Katebi

Bureau for Global Health, United States Agency for International Development, Arlington, VA, USA

Melanie Spillane

Instituto de Medicina Tropical & Salud Global, Universidad Iberoamericana, UNIBE Research Hub, Santo Domingo, Dominican Republic

Robert Paulino-Ramírez, Sayira Mueses, Armando Peguero & Nelissa Sánchez

National Referral Unit for Tropical Diseases, Infectious Diseases Department, CIBER de Enfermedades Infecciosas, IRYCIS, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain

Francesca F. Norman

Microbiology Department, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain

Juan-Carlos Galán

Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy

Ralph Huits

Department of Global Health, Boston University School of Public Health, Section of Infectious Diseases, Boston University School of Medicine, Center for Emerging Infectious Disease Policy and Research, Boston University, and National Emerging Infectious Disease Laboratory, Boston, MA, USA

Davidson H. Hamer

Yale Institute for Global Health, Yale University, New Haven, CT, USA

Chantal B. F. Vogels & Nathan D. Grubaugh

Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA

Nathan D. Grubaugh

You can also search for this author in PubMed   Google Scholar

Contributions

E.T.S, C.B.F.V, A.M., S.F.M., and N.D.G. designed the study. E.T.S., V.H., L.M.P., and R.T.K. wrote the paper. L.M.P., A.M., S.Bu., N.C., M.C., S.E., A.G., N.G., A.H., L.H., R.J., E.K., P.C., A.D., S.Ba., E.R., A.M.E., B.S., D.S., R.Z., R.P.R, S.M., A.P., N.S., F.F.N., J.C.G., J.L.M.J., G.A.S, L.E.A, G.P.B., R.H., and D.H.H. collected clinical samples and data. M.I.B, C.C., A.S., V.H., and C.B.F.V. performed the sequencing and bioinformatic analysis. M.S. and V.K. provided travel data. E.T.S., R.T.K., V.H., and J.L.W. performed statistical and phylogenetic analyses. N.D.G, C.B.F.V, A.M. and S.F.M supervised the project. All authors reviewed and approved the final version of the manuscript.

Corresponding authors

Correspondence to Emma Taylor-Salmon , Andrea Morrison , Scott F. Michael or Nathan D. Grubaugh .

Ethics declarations

Competing interests.

N.D.G. is a paid consultant for BioNTech for work unrelated to this manuscript. All other authors declare no competing interests.

Peer review

Peer review information.

Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary information, peer review file, reporting summary, rights and permissions.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .

Reprints and permissions

About this article

Cite this article.

Taylor-Salmon, E., Hill, V., Paul, L.M. et al. Travel surveillance uncovers dengue virus dynamics and introductions in the Caribbean. Nat Commun 15 , 3508 (2024). https://doi.org/10.1038/s41467-024-47774-8

Download citation

Received : 11 November 2023

Accepted : 11 April 2024

Published : 25 April 2024

DOI : https://doi.org/10.1038/s41467-024-47774-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

By submitting a comment you agree to abide by our Terms and Community Guidelines . If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

We've detected unusual activity from your computer network

To continue, please click the box below to let us know you're not a robot.

Why did this happen?

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy .

For inquiries related to this message please contact our support team and provide the reference ID below.